Editorial
Editorial
Adjuvant treatment
Place of gemcitabine in radiotherapy-chemotherapy combination regimens of stage III non-small cell lung cancer
Changes in the therapeutic strategies of metastatic non-small cell lung cancer
Current management strategies and value of polychemotherapy in the treatment of metastatic breast cancer
Optimising the use of taxanes as 1st line chemotherapy
Chemotherapy in the metastatic stage following treatment with anthracyclines and taxanes
Gemcitabine- and taxane-based protocols in breast cancer